Results 61 to 70 of about 2,498 (139)

Oral cabergoline for the management of equine pituitary pars intermedia dysfunction: Five cases

Open Veterinary Journal
Background: Oral pergolide has become the mainstay of treatment for equine pituitary pars intermedia dysfunction (PPID). It has a high success rate but some horses are, or become, refractory to the effects.
Eleanor M. Kellon
doaj   +1 more source

Is Hypercortisolism Treatable? Which Patients Should Be Treated and How—A Practical Guide for Clinicians

Diabetes, Obesity and Metabolism, Volume 28, Issue S4, Page 34-49, August 2026.
ABSTRACT Aim To provide a practical guide on when to suspect endogenous hypercortisolism, how to use the overnight 1‐mg dexamethasone suppression test (DST) for targeted case‐finding, and which patients are most likely to benefit from treatment.
Juan Pablo Frias
wiley   +1 more source

Cabergoline for preventing ovarian hyperstimulation syndrome

, 2012
Background Ovarian hyperstimulation syndrome (OHSS) is a complication resulting from administration of human chorionic gonadotrophin (hCG) in assisted reproduction technology (ART) treatment.
Huilin Tang, Yongfang Hu, Hu, Yongfang, Hunter, Tamara, Sheng, Xiaoyan, Hart, Roger J, Tamara Hunter, Suo-Di Zhai, Tang, Huilin, Zhai, Suo-Di, Xiaoyan Sheng, Roger J Hart   +11 more
core   +1 more source

The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome [PDF]

Iranian Journal of Medical Sciences, 2011
Type 2 receptors for vascular endothelial growth factor are believed to be involved in the pathophysiology of ovarian hyperstimulation syndrome (OHSS).
Marzieh Agha Hosseini, Ashraf Aleyasin, Atossa Mahdavi, Romina Nezami, Leila Safdarian   +4 more
doaj  

Can acromegaly be controlled in all cases?

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Acromegaly is a rare disease, due in most of the cases to a growth hormone (GH)‐secreting pituitary adenoma (PA), namely neuroendocrine tumour (PitNET). The treatment of patients with acromegaly is multimodal and multi‐step, including surgery, medical therapies, and radiotherapy.
Sabrina Chiloiro, Francesco Padovano Sorrentino, Alessandra Vicari, Antonella Giampietro, Pier Paolo Mattogno, Quintino Giorgio D'Alessandris, Rosalinda Calandrelli, Tommaso Tartaglione, Marco Gessi, Simona Gaudino, Laura De Marinis, Guido Rindi, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorvi   +14 more
wiley   +1 more source

Effect of dopamine agonist dose and treatment duration on fibrous tissue formation in prolactinomas

Alʹmanah Kliničeskoj Mediciny
Background: Currently, dopamine agonists are the established first-line therapy for prolactin-secreting pituitary adenomas. However, long-term treatment may be associated with the development of fibrotic changes within the adenoma tissue, which ...
Farida A. Nasybullina, Gulnar R. Vagapova, Bakhtiyar Yu. Pashayev, Regina R. Ashimova, Artur R. Khafizov   +4 more
doaj   +1 more source

Successful Management of a Giant Pituitary Lactosomatotroph Adenoma Only with Cabergoline

Case Reports in Endocrinology, 2013
Although advances in endocrinologic and neuroradiologic research allow easier recognition of pituitary adenomas, giant pituitary tumours are relatively rare.
Emre Bozkirli, Okan Bakiner, Emine Duygu Ersozlu Bozkirli, Eda Ertorer, Neslihan Bascil Tutuncu, Nilgun Guvener Demirag   +5 more
doaj   +1 more source

Rolf Christian Gaillard (1944–2011): A builder of modern European endocrinology and neuroendocrinology

Journal of Neuroendocrinology, Volume 38, Issue 8, August 2026.
Abstract Rolf Christian Gaillard was a Swiss physician, scientist, and academic leader whose career contributed significantly to the development of modern European endocrinology and neuroendocrinology. Among his most remarkable qualities was an exceptional talent for organisation and institution‐building.
Philippe Chanson, Eduardo Spinedi, François Pralong   +2 more
wiley   +1 more source

ACTH silent adenoma shrinking under cabergoline. [PDF]

, 2001
peer reviewedOBJECTIVES: The authors present a case report that proposes the use of cabergoline treatment in silent ACTH adenoma, an unusual member of the heterogeneous group of the so-called clinically non-functioning pituitary adenomas.
Petrossians, Patrick, Kalife, A., Stevenaert, Achille, Tabarin, A., Valdes Socin, Hernan Gonzalo, Ronci, N., Bloch, B., Beckers, Albert   +7 more
core   +1 more source

Cabergoline as a preventive migraine treatment: A randomized clinical pilot trial.

PLoS ONE
BackgroundBeneficial effects of dopamine agonist treatment on migraine have been reported but remain to be properly tested. The aim of this study was to examine the effect of cabergoline as preventive treatment for migraine.MethodsIn a double-blind ...
Astrid Johannesson Hjelholt, Flemming Winther Bach, Helge Kasch, Henrik Støvring, Troels Staehelin Jensen, Jens Otto Lunde Jørgensen   +5 more
doaj   +1 more source